Page 10 - Galt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Galt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Galt Today - Breaking & Trending Today

Galectin Therapeutics (NASDAQ:GALT) Coverage Initiated at StockNews.com

Equities researchers at StockNews.com assumed coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) in a report released on Sunday. The brokerage set a “hold” rating on the stock. Galectin Therapeutics Stock Performance GALT stock opened at $1.44 on Friday. The firm has a market cap of $85.62 million, a P/E ratio of -2.15 […] ....

Advisor Alliance , Geode Capital Management , Galectin Therapeutics Company Profile , Wealthspire Advisors , Virtu Financial , Galectin Therapeutics Inc , Galectin Therapeutics , Free Report , Capital Management , Street Group , Therapeutics Inc , Galectin Therapeutics Daily , Nasdaq Galt , Initiated Coverage , Stocknews Com ,

Galectin Therapeutics (NASDAQ:GALT) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Get Rating) in a report released on Saturday morning. The brokerage issued a hold rating on the stock. Separately, HC Wainwright reissued a buy rating and set a $11.00 target price on shares of Galectin Therapeutics in a research note on Friday, March 3rd. Galectin […] ....

Atria Wealth Solutions Inc , Galectin Therapeutics Inc , Commonwealth Equity Services , Wealthspire Advisors , Advisor Alliance , Galectin Therapeutics , Get Rating , Therapeutics Stock Down , Wealth Solutions , Equity Services , Jane Street Group , Therapeutics Inc , Galectin Therapeutics Daily , Nasdaq Galt , Initiated Coverage , Stocknews Com ,

Galectin Therapeutics (NASDAQ:GALT) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Get Rating) in a research note issued to investors on Friday morning. The firm issued a hold rating on the stock. Separately, HC Wainwright reissued a buy rating and issued a $11.00 price target on shares of Galectin Therapeutics in a research note on Friday, […] ....

Geode Capital Management , Financial Services Group Inc , Benjaminf Edwards Company Inc , Galectin Therapeutics Inc , Investors Services , Galectin Therapeutics , Get Rating , Therapeutics Trading Down , Capital Management , Services Group , Street Corp , Galectin Therapeutics Daily , Nasdaq Galt , Initiated Coverage , Stocknews Com ,

Galectin Therapeutics (NASDAQ:GALT) Receives New Coverage from Analysts at StockNews.com

StockNews.com began coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Get Rating) in a research report sent to investors on Friday morning. The firm issued a hold rating on the stock. Separately, HC Wainwright restated a buy rating and issued a $11.00 price target on shares of Galectin Therapeutics in a research note on Friday, […] ....

Benjaminf Edwards Company Inc , Centaurus Financial Inc , Virtu Financial , Galectin Therapeutics Inc , Galectin Therapeutics Company Profile , Citadel Advisors , Galectin Therapeutics , Get Rating , Street Group , Galectin Therapeutics Daily , Nasdaq Galt , Initiated Coverage , Stocknews Com ,

Galectin Therapeutics (NASDAQ:GALT) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Get Rating) in a research note issued on Thursday. The firm set a “hold” rating on the stock. Separately, HC Wainwright reiterated a “buy” rating and set a $11.00 price target on shares of Galectin Therapeutics in a research note on Friday, March 3rd. Galectin […] ....

Wealthspire Advisors , Galectin Therapeutics Inc , Millennium Management , Geode Capital Management , Atria Wealth Solutions Inc , Galectin Therapeutics , Get Rating , Capital Management , Wealth Solutions , State Street Corp , Street Corp , Galectin Therapeutics Daily , Nasdaq Galt , Initiated Coverage , Stocknews Com ,